Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · IEX Real-Time Price · USD
6.57
-0.06 (-0.90%)
Jun 20, 2024, 1:35 PM EDT - Market open

Acrivon Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year
2023202220212020
Cash & Equivalents
36.4329.9199.991.99
Short-Term Investments
91.4498.2300
Cash & Cash Equivalents
127.87128.1499.991.99
Cash Growth
-0.21%28.15%4924.67%-
Other Current Assets
1.823.960.42-0.27
Total Current Assets
129.69132.1100.411.72
Property, Plant & Equipment
7.916.865.790.06
Long-Term Investments
041.8800
Other Long-Term Assets
0.670.390.390.41
Total Long-Term Assets
8.5749.136.180.47
Total Assets
138.27181.23106.592.19
Accounts Payable
5.050.90.960.14
Current Debt
0.880.730.660
Other Current Liabilities
7.384.891.290.48
Total Current Liabilities
13.36.522.910.61
Long-Term Debt
3.774.244.960
Other Long-Term Liabilities
0000.32
Total Long-Term Liabilities
3.774.244.960.32
Total Liabilities
17.0710.757.880.93
Total Debt
4.644.965.630
Debt Growth
-6.39%-11.85%--
Retained Earnings
-116.42-56.03-24.87-8.62
Comprehensive Income
-0.08-0.100
Shareholders' Equity
121.2170.48-23.81-8.41
Net Cash / Debt
123.23123.1894.361.99
Net Cash / Debt Growth
0.04%30.54%4641.86%-
Net Cash Per Share
5.5829.8854.131.39
Working Capital
116.39125.5897.491.11
Book Value Per Share
5.4941.36-13.66-5.87
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).